[Federal Register Volume 64, Number 80 (Tuesday, April 27, 1999)]
[Notices]
[Page 22626]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-10457]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meetings
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting:
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5,
U.S.C. as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which
would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel--Development of Assay Methods for Creuzfeldt-
Jacob Disease.
Date: April 30, 1999.
Time: 8:00 a.m.
Agenda: To review and evaluate grant applications.
Place: Sheraton Columbia, Wincopin Circle, Columbia, Maryland
21044.
Contact Person: Jeffrey H. Hurst, Ph.D., Scientific Review
Administrator, NHLBI/Review Branch, Two Rockledge Center, Room 7208,
Bethesda, Maryland 20892-7924, (301) 435-0303.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Programs Nos. 93.837,
Heart and Vascular Diseases Research; 93.838, Lung Diseases
Research; and 93.839, Blood Diseases and Resources Research,
National Institutes of Health)
Dated: April 20, 1999.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 99-10457 Filed 4-26-99; 8:45 am]
BILLING CODE 4140-01-M
